KRT33B
Keratin, type I cuticular Ha3-II
Also known as: Ha-3II, KRTHA3B, KT33B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14525
- Gene
- KRT33B
- Ensembl
- ENSG00000131738
- Chromosome
- 17
- Canonical length
- 404 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol,Equatorial segment,Mid piece,Principal piece,End piece
OverviewNCBI Gene
This gene encodes a member of the keratin gene family. This gene is one of multiple type I hair keratin genes that are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription. As a type I hair keratin, the encoded protein is an acidic protein which heterodimerizes with type II keratins to form hair and nails. There are two isoforms of this protein, encoded by two separate genes, keratin 33A and keratin 33B. [provided by RefSeq, May 2012]
Canonical amino-acid sequenceUniProt
404 residues, UniProt reviewed canonical sequence.
>Q14525|KRT33B
1 MPYNFCLPSL SCRTSCSSRP CVPPSCHGYT LPGACNIPAN VSNCNWFCEG SFNGSEKETM
61 QFLNDRLASY LEKVRQLERD NAELENLIRE RSQQQEPLLC PSYQSYFKTI EELQQKILCS
121 KSENARLVVQ IDNAKLAADD FRTKYQTEQS LRQLVESDIN SLRRILDELT LCRSDLEAQM
181 ESLKEELLSL KQNHEQEVNT LRCQLGDRLN VEVDAAPAVD LNQVLNETRN QYEALVETNR
241 REVEQWFATQ TEELNKQVVS SSEQLQSYQA EIIELRRTVN ALEIELQAQH NLRYSLENTL
301 TESEARYSSQ LSQVQSLITN VESQLAEIRS DLERQNQEYQ VLLDVRARLE CEINTYRSLL
361 ESEDCKLPSN PCATTNACEK PIGSCVTNPC GPRSRCGPCN TFGYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRT33B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- skin: 74 nTPM
- thymus: 1.3 nTPM
- salivary gland: 1.1 nTPM
- adipose tissue: 0.6 nTPM
- cerebral cortex: 0.4 nTPM
- cervix: 0.2 nTPM
Single-cell type
- epididymal basal cells: 0.2 nCPM
- brain excitatory neurons: 0.1 nCPM
- extravillous trophoblasts: 0.1 nCPM
- migrating cytotrophoblasts: 0.1 nCPM
- suprabasal keratinocytes: 0.1 nCPM
- syncytiotrophoblasts: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 0.1 nTPM
- amygdala: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.47
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- epithelial cell differentiation
- hair cycle
- intermediate filament organization
- morphogenesis of an epithelium
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRT33B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRT33B as an antibody target. Whether an autoantibody or antibody against KRT33B could matter depends on whether native KRT33B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRT33B is annotated as secreted, so native KRT33B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label KRT33B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...